These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22515978)

  • 1. Th17-related cytokines in inflammatory bowel diseases: friends or foes?
    Monteleone I; Sarra M; Pallone F; Monteleone G
    Curr Mol Med; 2012 Jun; 12(5):592-7. PubMed ID: 22515978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease.
    Shen W; Durum SK
    Neurochem Res; 2010 Jun; 35(6):940-6. PubMed ID: 19915978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-23/IL-17 axis in IBD.
    Sarra M; Pallone F; Macdonald TT; Monteleone G
    Inflamm Bowel Dis; 2010 Oct; 16(10):1808-13. PubMed ID: 20222127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease.
    Liu ZJ; Yadav PK; Su JL; Wang JS; Fei K
    World J Gastroenterol; 2009 Dec; 15(46):5784-8. PubMed ID: 19998498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Th17 Cells in the Pathogenesis of Human IBD.
    Gálvez J
    ISRN Inflamm; 2014; 2014():928461. PubMed ID: 25101191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
    Vyas SP; Goswami R
    Front Immunol; 2018; 9():1139. PubMed ID: 29881387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and adaptive immunity in inflammatory bowel disease.
    Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
    Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation.
    Olsen T; Rismo R; Cui G; Goll R; Christiansen I; Florholmen J
    Cytokine; 2011 Dec; 56(3):633-40. PubMed ID: 21945121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interleukin-23 axis in intestinal inflammation.
    Ahern PP; Izcue A; Maloy KJ; Powrie F
    Immunol Rev; 2008 Dec; 226():147-59. PubMed ID: 19161422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartmentalized expression of Th1 and Th17 cytokines in pediatric inflammatory bowel diseases.
    Verdier J; Begue B; Cerf-Bensussan N; Ruemmele FM
    Inflamm Bowel Dis; 2012 Jul; 18(7):1260-6. PubMed ID: 21994045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
    Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
    J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.